Skip links

Dabigatran Etexilate Mesylate

Home / API - Under Development / Dabigatran Etexilate Mesylate
CAS No.
Therapeutic Category
Innovator Brand
Pradaxa, Pradax, Prazaxa
GMP
Available
DMF
Not Available
Filed
-
Under Filing
-
Sample
Available
Indication

Dabigatran, sold under the brand name Pradaxa among others, is an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. Specifically it is used to prevent blood clots following hip or knee replacement and in those with a history of prior clots.

Dabigatran is used to prevent strokes in those with atrial fibrillation not caused by heart valve issues, as well as deep vein thrombosis and pulmonary embolism in persons who have been treated for 5–10 days with parenteral anticoagulant (usually low molecular weight heparin), and to prevent deep vein thrombosis and pulmonary embolism in some circumstances.

Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.

Send Enquiry